A Phase I Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of A140 Injection and Cetuximab (Erbitux®) in Healthy Chinese Male Subjects.
| Publicado en: | Advances in Therapy Vol. 42; no. 6; pp. 2797 - 2808 |
|---|---|
| Autores principales: | , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
Jun2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=185237585&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 185237585 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 0741238X 1XDX jtl: Advances in Therapy issn: 0741238X maglogo: N pubinfo: dt: Jun2025 vid: 42 iid: 6 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 185237585 184488558 10.1007/s12325-025-03193-9 185237585 ppf: 2797 ppct: 11 formats: tig: atl: A Phase I Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of A140 Injection and Cetuximab (Erbitux®) in Healthy Chinese Male Subjects. aug: au: Xu, Jia Ge, Junyou Li, Yaling Liu, Shulin Li, Sicong Si, Jing Liu, Juncheng Zhu, Xiaoxue Ding, Yanhua affil: https://ror.org/034haf133 Phase I Clinical Trial Unit, The First Hospital of Jilin University, Changchun, Jilin, China sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|